Covidien Hernia Mesh Verdict: $88 Million in the First MDL Bellwether
On August 4, 2026, a federal jury in Boston returned an $88 million compensatory verdict against Covidien in the first case from MDL-3029 to reach trial. It is the largest reported compensatory award in U.S. hernia mesh litigation. It is also a verdict rather than a settlement, a distinction that several published summaries have gotten wrong, and Medtronic has said it will appeal.
This was a verdict, not a settlement
Several pages published after August 4 describe the $88 million as a settlement. It was not. A jury heard the evidence and returned a damages award against Covidien, which the company is contesting. The practical difference matters: a settlement is money the parties agree to pay, while a verdict under appeal may be reduced, overturned, or retried, and it may be years before anything is paid. If you have seen this reported as a settlement, that reporting is inaccurate.
What we know
- The verdict
- $88 million in compensatory damages: $77 million to Larry Patterson and $11 million to Tammy Patterson on her loss-of-consortium claim.
- The case
- Patterson v. Covidien, the first case from MDL-3029 to reach trial, before Judge Patti B. Saris in the U.S. District Court for the District of Massachusetts.
- The theory
- Failure to warn. The jury found Covidien did not adequately warn physicians about the risks of its Symbotex Composite mesh.
- What the jury rejected
- The jury declined to award punitive damages and rejected the allegation that Covidien acted intentionally or recklessly in making false statements.
- The defense response
- Medtronic, which acquired Covidien in 2015, said it disagrees with the verdict and will pursue post-trial motions and an appeal.
What's still unknown
- Whether $88 million stands
- A verdict is not a payment. Post-trial motions and an appeal are pending or expected, and courts can reduce or set aside an award. No money has changed hands.
- What other cases are worth
- Nothing here establishes a value for any other claim. A bellwether tests one plaintiff's facts. Individual outcomes depend on the product, the injury, the timeline, and the evidence in that case.
- Whether a global settlement follows
- None has been announced. Court-ordered mediation in this MDL ended without a global resolution earlier in 2026.
- The next trial date
- No second bellwether trial date has been publicly reported as of this writing.
Key Takeaways
- A Massachusetts federal jury awarded $88 million against Covidien on August 4, 2026: $77 million to Larry Patterson and $11 million to Tammy Patterson
- The case, Patterson v. Covidien, was the first of roughly 2,449 pending MDL-3029 cases to reach a jury
- The jury found failure to warn physicians about Symbotex Composite mesh, but declined punitive damages and rejected the intentional misrepresentation claim
- This is a verdict, not a settlement. Medtronic is pursuing post-trial motions and appeal, and the award is not final
- No global settlement has been announced in MDL-3029, and the verdict does not set a value for any other claim
What the jury heard
The case centered on a Symbotex Composite mesh patch implanted in Larry Patterson in 2017 to repair an incisional hernia. Composite meshes like Symbotex pair a polyester base with an absorbable collagen barrier. The barrier is the part that is supposed to keep the mesh from fusing to the organs it sits against while the body heals a protective layer of tissue over it. The plaintiffs alleged that Covidien's barrier resorbed in roughly seven days rather than the approximately thirty days represented, leaving the raw polyester exposed to bowel far earlier than surgeons were led to expect. Patterson later required a second operation in which surgeons removed the mesh along with several inches of intestine.
After a trial of roughly three weeks, the jury agreed that Covidien failed to give physicians adequate warning of that risk. It did not go further. Jurors declined to award punitive damages and rejected the allegation that the company acted intentionally or recklessly in making false statements. That split matters. A failure-to-warn finding without a finding of intentional misconduct is a narrower verdict than the headline number suggests, and it is the kind of record that gives a defendant material to work with on appeal.
Why a bellwether verdict is not a payout
MDL-3029 consolidates federal Covidien hernia mesh cases before Judge Patti B. Saris in the District of Massachusetts, where roughly 2,449 actions were pending as of the August 1, 2026 JPML report. Thousands of additional claims sit in Massachusetts and Minnesota state courts. Bellwether trials exist to test representative cases so both sides can price the rest of the inventory. They are informational, not binding on anyone else.
Practically, that means three things for anyone with a Covidien mesh claim. The $88 million figure is not a per-case value and never will be. The verdict itself is unresolved while post-trial motions and an appeal run their course, a process that commonly takes a year or more and can end in a reduced award, a new trial, or a reversal. And no global settlement exists in this MDL; court-ordered mediation ended earlier in 2026 without one, which is precisely why the case went to trial in the first place.
What a verdict like this does change is negotiating posture. A defendant that has just watched a jury award $88 million on a failure-to-warn theory evaluates the remaining docket differently than one that has never lost. Whether that produces settlement discussions, and on what terms, is not something anyone can responsibly predict right now.
Where the litigation goes next
The near-term markers to watch are Covidien's post-trial motions, including any motion for judgment as a matter of law or for remittitur to reduce the award, and whether Judge Saris sets a second bellwether. Neither has been reported as resolved or scheduled as of this writing. The Massachusetts state court inventory, which press reports put at several thousand cases, is a separate track with its own timeline.
This is general litigation reporting and not legal advice. Filing deadlines vary by state and by when an injury was discovered, and they can bar a claim regardless of its merits. Anyone weighing a claim should get their operative report, confirm which mesh was actually implanted, and speak with a licensed attorney about their own situation.
Full Covidien hernia mesh background & eligibility
For the complete overview, including the products in litigation, the FDA recall history, the reported complications, and how cases proceed, visit our case hub.
Sources
- • Reuters, reporting on the Patterson v. Covidien bellwether verdict (Aug 4-5, 2026).
- • MassDevice, "Jury says Medtronic must pay $88M in Covidien hernia mesh suit" (Aug 5, 2026), including Medtronic's statement.
- • HarrisMartin, "Trial in Bellwether Covidien Hernia Mesh Action Ends in $88M Verdict" (Aug 2026).
- • Star Tribune, "Bellwether hernia case ends in $88M verdict against Medtronic" (Aug 2026).
- • JPML, Pending MDL Dockets by Actions Pending (Aug 1, 2026); D. Mass. MDL-3029 docket before Hon. Patti B. Saris.
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content.
Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.